In Silico Discovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer-Reference-Cited by-同舟云学术

In Silico Discovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer

Published:2012-11-01 Issue:11 Volume:26 Page:1836-1846
ISSN:0888-8809
Container-title:Molecular Endocrinology
language:en
Short-container-title:

Author:

Shen Howard C.¹,Shanmugasundaram Kumaran²,Simon Nicholas I.¹,Cai Changmeng¹,Wang Hongyun¹,Chen Sen¹,Balk Steven P.¹,Rigby Alan C.²³

Affiliation:

1. Divisions of Hematology-Oncology (H.C.S., N.I.S., C.C., H.W., S.C., S.P.B.), Harvard Medical School, Boston, Massachusetts 02215

2. Molecular and Vascular Medicine (K.S., A.C.R.), Harvard Medical School, Boston, Massachusetts 02215

3. Center for Vascular Biology Research (A.C.R.), Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Publisher

The Endocrine Society

Subject

Endocrinology,Molecular Biology,General Medicine

Link

http://academic.oup.com/mend/article-pdf/26/11/1836/8934566/mend1836.pdf

Reference32 articles.

1. Steroid hormone receptors in prostate cancer: a hard habit to break?;Attard;Cancer Cell,2009

2. Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven.;Attard;Cancer Res,2009

3. High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy.;Joyce;J Urol,1998

4. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.;Taplin;Cancer Res,1999

5. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.;Taplin;J Clin Oncol,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target?;Frontiers in Cell and Developmental Biology;2022-12-13

2. Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy;JCI Insight;2019-09-05

3. Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction;International Journal of Molecular Sciences;2018-06-15

4. Pharmacophore Models for Toxicology Prediction;Computational Toxicology;2018-01-19

5. Identification of Unknown Antiandrogenic Compounds in Surface Waters by Effect-Directed Analysis (EDA) Using a Parallel Fractionation Approach;Environmental Science & Technology;2017-12-19